Notch pathway regulates osimertinib drug-tolerant persistence in EGFR-mutated non-small-cell lung cancer.
Takahashi H, Sakakibara-Konishi J, Furuta M, Shoji T, Tsuji K, Morinaga D, Kikuchi E, Kikuchi J, Noguchi T, Hatanaka KC, Hatanaka Y, Shinagawa N, Konno S.
Takahashi H, et al. Among authors: hatanaka kc, hatanaka y.
Cancer Sci. 2023 Apr;114(4):1635-1650. doi: 10.1111/cas.15674. Epub 2022 Dec 7.
Cancer Sci. 2023.
PMID: 36411521
Free PMC article.